ArticleOpen forum infectious diseases2026
Calprotectin as a Diagnostic Marker for Lower Respiratory Tract Infection and Sepsis in the Emergency Department.
Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Calprotectin, a neutrophil activation marker, is a promising diagnostic biomarker for infection and sepsis, but its usefulness in the emergency department (ED) is unclear. The aim of this study was to investigate the diagnostic value of calprotectin for sepsis and the source of infection in the ED. Methods: A total of 583 prospectively included patients presenting with suspected sepsis to the ED of a university hospital in southern Sweden were analyzed. Calprotectin was measured in plasma samples obtained at admission. Results: Mean age was 69 years and 49% were female. Calprotectin discriminated between sepsis and noninfectious systemic inflammatory response syndrome with an area under the curve (AUC) of 0.63, but was not an independent predictor in multivariable analysis including C-reactive protein (CRP). The Modified Early Warning Score did not show any discriminatory ability. Calprotectin and CRP discriminated between lower respiratory tract infection and (1) upper respiratory tract infection, (2) urinary tract infection, and (3) other sources of infection. Addition of calprotectin to CRP significantly increased the AUC for lower versus upper respiratory tract infection and lower respiratory tract infection versus urinary tract infection. Calprotectin was an independent predictor for all outcomes while CRP was only an independent predictor of lower versus upper respiratory tract infection. Conclusions: Calprotectin may improve differentiation of lower respiratory tract infections from upper respiratory tract infections and urinary tract infections in patients presenting to the ED with sepsis. Further research is needed to clarify if calprotectin adds diagnostic value to standard clinical assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.